IS7724A - Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat - Google Patents

Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat

Info

Publication number
IS7724A
IS7724A IS7724A IS7724A IS7724A IS 7724 A IS7724 A IS 7724A IS 7724 A IS7724 A IS 7724A IS 7724 A IS7724 A IS 7724A IS 7724 A IS7724 A IS 7724A
Authority
IS
Iceland
Prior art keywords
tablets
magnesium carbonate
composition
containing heavy
rapid decomposition
Prior art date
Application number
IS7724A
Other languages
English (en)
Inventor
Torfi Emil Kristjansson
Original Assignee
Actavis Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group filed Critical Actavis Group
Priority to IS7724A priority Critical patent/IS7724A/is
Priority to US11/885,417 priority patent/US20080166406A1/en
Priority to CNA2006800069782A priority patent/CN101132764A/zh
Priority to CA002599308A priority patent/CA2599308A1/en
Priority to AT06711375T priority patent/ATE446084T1/de
Priority to DE202006020222U priority patent/DE202006020222U1/de
Priority to EP06711375A priority patent/EP1863443B1/en
Priority to JP2007557680A priority patent/JP2008531681A/ja
Priority to PCT/IS2006/000005 priority patent/WO2006092812A2/en
Priority to DE602006009906T priority patent/DE602006009906D1/de
Publication of IS7724A publication Critical patent/IS7724A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IS7724A 2005-03-02 2005-03-02 Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat IS7724A (is)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IS7724A IS7724A (is) 2005-03-02 2005-03-02 Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
US11/885,417 US20080166406A1 (en) 2005-03-02 2006-03-02 Rapidly Disintegrating Dosage Form Comprising Magnesium Carbonate Heavy
CNA2006800069782A CN101132764A (zh) 2005-03-02 2006-03-02 含重质碳酸镁的快速崩解剂型
CA002599308A CA2599308A1 (en) 2005-03-02 2006-03-02 Rapidly disintegrating dosage form comprising magnesium carbonate heavy
AT06711375T ATE446084T1 (de) 2005-03-02 2006-03-02 Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform
DE202006020222U DE202006020222U1 (de) 2005-03-02 2006-03-02 Schnell zerfallende Darreichungsform umfassend Magnesiumcarbonat schwer
EP06711375A EP1863443B1 (en) 2005-03-02 2006-03-02 Rapidly disintegrating dosage form comprising magnesium carbonate heavy
JP2007557680A JP2008531681A (ja) 2005-03-02 2006-03-02 炭酸マグネシウムヘビーを含む速崩壊型製剤
PCT/IS2006/000005 WO2006092812A2 (en) 2005-03-02 2006-03-02 Rapidly disintegrating dosage form comprising magnesium carbonate heavy
DE602006009906T DE602006009906D1 (de) 2005-03-02 2006-03-02 Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS7724A IS7724A (is) 2005-03-02 2005-03-02 Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat

Publications (1)

Publication Number Publication Date
IS7724A true IS7724A (is) 2006-09-03

Family

ID=36922130

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7724A IS7724A (is) 2005-03-02 2005-03-02 Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat

Country Status (9)

Country Link
US (1) US20080166406A1 (is)
EP (1) EP1863443B1 (is)
JP (1) JP2008531681A (is)
CN (1) CN101132764A (is)
AT (1) ATE446084T1 (is)
CA (1) CA2599308A1 (is)
DE (2) DE602006009906D1 (is)
IS (1) IS7724A (is)
WO (1) WO2006092812A2 (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689371A2 (en) * 2003-11-25 2006-08-16 Aurobindo Pharma Limited Pharmaceutical compositions of mirtazapine
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
WO2009118760A2 (en) * 2008-03-26 2009-10-01 Matrix Laboratories Limited Lanthanum composition
WO2009150665A1 (en) * 2008-06-09 2009-12-17 Lupin Limited Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof
US8343978B2 (en) * 2008-08-04 2013-01-01 Adds Pharmaceuticals Llc Fast onset orodispersable tablets
EP2198857A1 (en) 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
DE102009041839A1 (de) * 2009-09-18 2011-03-24 Dolorgiet Gmbh & Co. Kg Donepezil-haltige Tabletten
WO2011121824A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 口腔内崩壊錠
JP5614445B2 (ja) * 2010-03-29 2014-10-29 アステラス製薬株式会社 経口投与用粒子状医薬組成物
EP2377522B1 (en) * 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
EP2387993B1 (en) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
WO2013172805A1 (en) * 2012-05-14 2013-11-21 Mahmut Bilgic New orodispersible tablet formulations of olanzapine
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
US20150273062A1 (en) * 2012-09-18 2015-10-01 Merck Patent Gmbh Magnesium hydroxide carbonate as carrier material in active ingredient-containing preparations
BR112015014739A2 (pt) * 2012-12-21 2017-07-11 Merck Patent Gmbh carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
CN103284969B (zh) * 2013-07-01 2015-05-27 南京正宽医药科技有限公司 一种利培酮分散片及其制备方法
CN103520169B (zh) * 2013-10-25 2015-07-15 山东鲁药制药有限公司 米氮平片及其制备方法
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
JP2017014119A (ja) * 2015-06-26 2017-01-19 東和薬品株式会社 経口医薬組成物
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111714463B (zh) * 2020-08-14 2022-06-17 华农(肇庆)生物产业技术研究院有限公司 米氮平口服剂及其制备方法
CN115252568A (zh) * 2022-08-26 2022-11-01 苏州中化药品工业有限公司 一种盐酸西替利嗪片剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2147743A (en) * 1938-08-05 1939-02-21 Baker Chem Co J T Pharmaceutical preparation
GB1422176A (en) * 1973-05-05 1976-01-21 Beecham Group Ltd Pharmaceutical tablets
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
CA2128820A1 (en) 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
ES2217410T3 (es) 1996-04-16 2004-11-01 Novartis Consumer Health S.A. Forma de dosificacion oral de rapida desintegracion.
DE69934505T2 (de) 1998-05-18 2007-10-04 Takeda Pharmaceutical Co. Ltd. Im munde zerfallende tablette enthaltend ein benzimidazole
US6635278B1 (en) * 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations

Also Published As

Publication number Publication date
WO2006092812A3 (en) 2006-12-21
CA2599308A1 (en) 2006-09-08
DE602006009906D1 (de) 2009-12-03
EP1863443B1 (en) 2009-10-21
WO2006092812A2 (en) 2006-09-08
US20080166406A1 (en) 2008-07-10
JP2008531681A (ja) 2008-08-14
DE202006020222U1 (de) 2008-06-05
ATE446084T1 (de) 2009-11-15
CN101132764A (zh) 2008-02-27
EP1863443A2 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
IS7724A (is) Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
CA121249S (en) Electrode array
MX2009013255A (es) Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta.
MX2008008321A (es) Metodos para elaborar articulos polimericos y los articulos polimericos formados por este medio.
TW200740956A (en) Organic electroluminescent devices
GB2453907A (en) High performance ultracapacitors with carbon nanomaterials and ionic liquids
TW200644719A (en) OLEDs utilizing direct injection to the triplet state
USRE46162E1 (en) Water closet
CA114551S (en) Closure
WO2007096708A3 (en) Macro-diacrylates and macro-polyacrylates
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
WO2007134845A3 (en) Olanzapine pharmaceutical composition
AU308405S (en) Insect trap
TW200642190A (en) Dual compression contact and interposer connector comprising the same
TW200742486A (en) Electroluminescent device and electroluminescent device unit
TW200715551A (en) Method of forming a self-aligned transistor and structure therefor
WO2008132716A3 (en) Biocidic household cleansing materials
CA113786S (en) Lever
MD3122B1 (en) Electrolyte for steel dimensional electrochemical treatment
WO2007105252A8 (en) Use of magnesium-copper compositions for the evaporation of magnesium and magnesium dispensers
USD573391S1 (en) Portable water fountain
ATE506264T1 (de) Gegenüber abnutzung optimierter transportbehälter
AU309602S (en) Tapware - Hob mounted single lever mixer tap
AU309601S (en) Tapware - Basin mounted single lever mixer tap
AU309607S (en) Tapware - Wall mounted single lever mixer square